Skip to main content
Top
Published in: Acta Diabetologica 2/2019

01-02-2019 | Original Article

A 9 years comparison of weight loss, disappearance of obesity, and resolution of diabetes mellitus with biliointestinal bypass and with adjustable gastric banding: experience of a collaborative network

Authors: Antonio E. Pontiroli, Ahmed S. Zakaria, Giancarlo Micheletto, Chiara Osio, Alessandro Saibene, Franco Folli, On Behalf of the LAGB10 Group

Published in: Acta Diabetologica | Issue 2/2019

Login to get access

Abstract

Aims

Long-term comparisons between bariatric surgical techniques have been performed for gastric bypass (RYGB), sleeve gastrectomy (LSG), and biliopancreatic diversion (BPD) vs gastric banding (LAGB), but short-term studies (6 months–4 years) have only compared biliointestinal bypass (BIBP) and LAGB. The participating institutions regularly perform both BIBP and LAGB with a common protocol, and the aim of this retrospective study was to compare long-term effects of the two procedures on body weight, on clinical and metabolic variables, and on resolution of obesity and of diabetes.

Methods

All procedures performed between 01/01/1998 and 31/12/2005 were considered; 73 out of 91 patients undergoing BIBP, and 154 out of 249 patients undergoing LAGB were evaluable up to 9 years.

Results

BIBP was significantly more effective than LAGB in terms of weight loss and of resolution of obesity (BMI < 30 kg/m2), in terms of decrease of systolic blood pressure and of serum cholesterol, and similar in terms of resolution of diabetes. In addition, the effect of BIBP was stable, while the effect of LAGB decreased with time.

Conclusions

Both BIBP and LAGB exert long-term effects on body weight, on blood pressure, and on resolution of diabetes mellitus; the effect of BIBP is significantly greater than the effect of LAGB in terms of weight loss, resolution of obesity, of control of systolic blood pressure and of serum cholesterol, but not in terms of resolution of diabetes.
Literature
1.
go back to reference Amin PB, Weiner M (2010) Conversion of intestinal bypass to Roux-en-Y gastric bypass: a case report and brief review. Obes Surg 20:804–807CrossRefPubMed Amin PB, Weiner M (2010) Conversion of intestinal bypass to Roux-en-Y gastric bypass: a case report and brief review. Obes Surg 20:804–807CrossRefPubMed
2.
go back to reference Ikramuddin S, Kellogg TA, Leslie DB (2007) Laparoscopic conversion of vertical banded gastroplasty to a Roux-en-Y gastric bypass. Surg Endosc 21:1927–1930CrossRefPubMed Ikramuddin S, Kellogg TA, Leslie DB (2007) Laparoscopic conversion of vertical banded gastroplasty to a Roux-en-Y gastric bypass. Surg Endosc 21:1927–1930CrossRefPubMed
3.
go back to reference O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA (2013) Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg 257:87–94CrossRefPubMed O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA (2013) Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg 257:87–94CrossRefPubMed
4.
6.
go back to reference Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256CrossRefPubMed Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256CrossRefPubMed
7.
8.
go back to reference Doldi SB, Lattuada E, Zappa MA, Pieri G, Restelli A, Micheletto G (1998) Biliointestinal bypass: another surgical option. Obes Surg 8:566–569CrossRefPubMed Doldi SB, Lattuada E, Zappa MA, Pieri G, Restelli A, Micheletto G (1998) Biliointestinal bypass: another surgical option. Obes Surg 8:566–569CrossRefPubMed
9.
go back to reference Del Genio G, Gagner M, Limongelli P et al (2016) Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment. Surg Obes Relat Dis 12:815–821CrossRefPubMed Del Genio G, Gagner M, Limongelli P et al (2016) Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment. Surg Obes Relat Dis 12:815–821CrossRefPubMed
10.
go back to reference Dolan K, Hatzifotis M, Newbury L, Fielding G (2004) A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 14:165–169CrossRefPubMed Dolan K, Hatzifotis M, Newbury L, Fielding G (2004) A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 14:165–169CrossRefPubMed
11.
go back to reference Parikh M, Ayoung-Chee P, Romanos E et al (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 205:631–635CrossRefPubMed Parikh M, Ayoung-Chee P, Romanos E et al (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 205:631–635CrossRefPubMed
12.
go back to reference Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB (2009) A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 250:631–641PubMed Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB (2009) A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 250:631–641PubMed
13.
go back to reference Pontiroli AE, Laneri M, Veronelli A et al (2009) Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol 8:37CrossRefPubMedPubMedCentral Pontiroli AE, Laneri M, Veronelli A et al (2009) Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol 8:37CrossRefPubMedPubMedCentral
14.
go back to reference Padwal R, Klarenbach S, Wiebe N et al (2011) Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev 12:602–621CrossRefPubMed Padwal R, Klarenbach S, Wiebe N et al (2011) Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev 12:602–621CrossRefPubMed
15.
go back to reference Chakravarty PD, McLaughlin E, Whittaker D et al (2012) Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 10:172–182CrossRefPubMed Chakravarty PD, McLaughlin E, Whittaker D et al (2012) Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 10:172–182CrossRefPubMed
16.
go back to reference Angrisani L, Cutolo PP, Formisano G, Nosso G, Vitolo G (2013) Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis 9:405–413CrossRefPubMed Angrisani L, Cutolo PP, Formisano G, Nosso G, Vitolo G (2013) Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis 9:405–413CrossRefPubMed
17.
go back to reference Caiazzo R, Lassailly G, Leteurtre E et al (2014) Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 260:893–898CrossRefPubMed Caiazzo R, Lassailly G, Leteurtre E et al (2014) Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 260:893–898CrossRefPubMed
18.
go back to reference Corradini SG, Eramo A, Lubrano C et al (2005) Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 15:367–377CrossRefPubMed Corradini SG, Eramo A, Lubrano C et al (2005) Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 15:367–377CrossRefPubMed
19.
go back to reference Frige’ F, Laneri M, Veronelli A et al (2009) Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 19:198–204CrossRefPubMed Frige’ F, Laneri M, Veronelli A et al (2009) Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 19:198–204CrossRefPubMed
20.
go back to reference Benetti A, Del Puppo M, Crosignani A et al (2013) Cholesterol metabolism after bariatric surgery in grade 3 obesity. Differences between malabsorptive and restrictive procedures. Diabetes Care 36:1443–1447CrossRefPubMedPubMedCentral Benetti A, Del Puppo M, Crosignani A et al (2013) Cholesterol metabolism after bariatric surgery in grade 3 obesity. Differences between malabsorptive and restrictive procedures. Diabetes Care 36:1443–1447CrossRefPubMedPubMedCentral
21.
go back to reference Lubrano C, Mariani S, Badiali M et al (2010) Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes 34:1404–1414CrossRef Lubrano C, Mariani S, Badiali M et al (2010) Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes 34:1404–1414CrossRef
22.
go back to reference Pontiroli AE, Gniuli D, Mingrone G (2010) Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. Obes Surg 20:474–479CrossRefPubMed Pontiroli AE, Gniuli D, Mingrone G (2010) Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. Obes Surg 20:474–479CrossRefPubMed
23.
go back to reference Alam I, Stephens JW, Fielding A, Lewis KE, Lewis MJ, Baxter JN (2012) Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis 8:752–763CrossRefPubMed Alam I, Stephens JW, Fielding A, Lewis KE, Lewis MJ, Baxter JN (2012) Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis 8:752–763CrossRefPubMed
24.
go back to reference Pontiroli AE, Zakaria AS, Mantegazza E et al (2016) Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study. Cardiovasc Diabetol 15:39CrossRefPubMedPubMedCentral Pontiroli AE, Zakaria AS, Mantegazza E et al (2016) Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study. Cardiovasc Diabetol 15:39CrossRefPubMedPubMedCentral
25.
go back to reference Pontiroli AE, Pizzocri P, Librenti MC et al (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555–3561CrossRefPubMed Pontiroli AE, Pizzocri P, Librenti MC et al (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555–3561CrossRefPubMed
27.
go back to reference Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4:e297CrossRefPubMedPubMedCentral Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4:e297CrossRefPubMedPubMedCentral
28.
go back to reference Suter M, Calmes JM, Paroz A, Giusti V (2006) A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 16:829–835CrossRefPubMed Suter M, Calmes JM, Paroz A, Giusti V (2006) A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 16:829–835CrossRefPubMed
29.
go back to reference Tolonen P, Victorzon M, Mäkelä J (2008) 11-year experience with laparoscopic adjustable gastric banding for morbid obesity–what happened to the first 123 patients? Obes Surg 18:251–255CrossRefPubMed Tolonen P, Victorzon M, Mäkelä J (2008) 11-year experience with laparoscopic adjustable gastric banding for morbid obesity–what happened to the first 123 patients? Obes Surg 18:251–255CrossRefPubMed
30.
go back to reference Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S (2012) Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc 26:1909–1919CrossRefPubMed Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S (2012) Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc 26:1909–1919CrossRefPubMed
31.
go back to reference Zakaria AS, Rossetti L, Cristina M et al (2016) Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis 12:587–595CrossRefPubMed Zakaria AS, Rossetti L, Cristina M et al (2016) Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis 12:587–595CrossRefPubMed
32.
go back to reference Pontiroli AE, Morabito A (2011) Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 253:484–487CrossRefPubMed Pontiroli AE, Morabito A (2011) Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 253:484–487CrossRefPubMed
33.
go back to reference Scicali R, Rosenbaum D, Di Pino A et al (2018) An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects. Acta Diabetol 55:741–749CrossRefPubMed Scicali R, Rosenbaum D, Di Pino A et al (2018) An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects. Acta Diabetol 55:741–749CrossRefPubMed
34.
go back to reference Salehidoost R, Mansouri A, Amini M, Yamini SA, Aminorroaya A (2018) Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta Diabetol 55:569–577CrossRefPubMed Salehidoost R, Mansouri A, Amini M, Yamini SA, Aminorroaya A (2018) Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta Diabetol 55:569–577CrossRefPubMed
Metadata
Title
A 9 years comparison of weight loss, disappearance of obesity, and resolution of diabetes mellitus with biliointestinal bypass and with adjustable gastric banding: experience of a collaborative network
Authors
Antonio E. Pontiroli
Ahmed S. Zakaria
Giancarlo Micheletto
Chiara Osio
Alessandro Saibene
Franco Folli
On Behalf of the LAGB10 Group
Publication date
01-02-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1221-0

Other articles of this Issue 2/2019

Acta Diabetologica 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.